by | Oct 2, 2025 | Lupus Foundation of America, News & Events
In a new study, researchers found people with clinically active systemic lupus erythematosus (SLE) disease on standard of care can attain or achieve low disease activity (LLDAS) and meet the Definition of Remission in SLE (DORIS remission). Many people did not reach...
by | Sep 26, 2025 | Lupus Foundation of America
In the Jewish tradition, Yom Kippur—the holiest day of the year—is a 25-hour Day of Atonement devoted to self-reflection, repentance (teshuvah), and prayer. Fasting during this time is intended to shift focus from physical needs to spiritual renewal and a deeper sense...
by | Sep 26, 2025 | Lupus Foundation of America
The Lupus Foundation of America (LFA) plays a vital role in shaping policies that improve the lives of people affected by lupus. Led by our advocacy and government relations department, we work with elected officials and engage federal agencies such as the Food and...
by | Sep 22, 2025 | Lupus Foundation of America, News & Events
AstraZeneca announced that the Phase III TULIP-SC trial of SAPHNELO (anifrolumab) for treatment of people with systemic lupus erythematosus met its primary endpoint. Trial results showed that subcutaneous administration of the therapy demonstrated a statistically...
by | Sep 19, 2025 | Lupus Foundation of America
The Lupus Foundation of America is proud to share its 2025 Impact Report, which highlights the progress we’ve made together to improve the lives of people affected by lupus.The stories and outcomes featured in the report show how we’re advancing our core strategic...
by | Sep 15, 2025 | Lupus Foundation of America
En Español This Hispanic Heritage Month, we celebrate the strength, resilience and leadership of the Hispanic/Latino community. Lupus has a profound impact on this community, and the Lupus Foundation of America’s work to provide support, education and resources...
